Last reviewed · How we verify

NCT03293628

Comparing Two Techniques of Haemostasis After Cervical Conization

Completed Phase 2 Last updated 28 September 2017
What this trial tests

Phase 2 trial testing Vaginal Packing in Cervical Intraepithelial Neoplasia in 100 participants. Completed in 30 January 2016.

Timeline
1 October 2014
Primary endpoint
30 June 2015
30 January 2016

Quick facts

Lead sponsorBarretos Cancer Hospital
PhasePhase 2
StatusCompleted
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingsingle
Primary purposetreatment
Enrollment100
Start date1 October 2014
Primary completion30 June 2015
Estimated completion30 January 2016
Sites1 location across Brazil

Drugs / interventions tested

Conditions studied

Sponsor

Barretos Cancer Hospital

Who can join

Adults 19 to 68, female only, with Cervical Intraepithelial Neoplasia or Cervix Neoplasm. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The LEEP conization is commonly used for cervical pathologies treatment. The techniques for hemostasis usually used are: cautery, Monsel's solution and vaginal pack. Actually, there is no consensus about the best technique and there is not much information that validates the use of some of that. To compare the use or not of vaginal pack as methods of hemostasis after LEEP conization for management of cervical lesions.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other recruiting trials for Cervical Intraepithelial Neoplasia

Currently open trials in the same condition.

Other Barretos Cancer Hospital trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03293628.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing